Substrate and drug binding sites in LeuT.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Current Opinion in Structural Biology

• Publication date

  2010-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.sbi.2010.05.007PMID 20739005PMCID PMC2925194
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bivalent phenethylamines as novel dopamine transporter inhibitors: evidence for multiple substrate‐binding sites in a single transporter

  2010cited by this paper
• Crystal structure of the carnitine transporter and insights into the antiport mechanism

  2010cited by this paper
• Neurotransmitter Transporters: "Structure, Function, And Regulation"

  2010cited by this paper
• GABA transporter lysine 448: a key residue for tricyclic antidepressants interaction

  2009cited by this paper
• Binding and Orientation of Tricyclic Antidepressants within the Central Substrate Site of the Human Serotonin Transporter*

  2009cited by this paper
• An extended study of dimeric phenyl tropanes.

  2009cited by this paper
• Antidepressant specificity of serotonin transporter suggested by three LeuT–SSRI structures

  2009cited by this paper
• Mutational Mapping and Modeling of the Binding Site for (S)-Citalopram in the Human Serotonin Transporter*

  2009cited by this paper
• Location of the Antidepressant Binding Site in the Serotonin Transporter

  2009cited by this paper
• From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.

  2008cited by this paper
• The binding sites for cocaine and dopamine in the dopamine transporter overlap

  2008cited by this paper
• Comparative Molecular Field Analysis Using Selectivity Fields Reveals Residues in the Third Transmembrane Helix of the Serotonin Transporter Associated with Substrate and Antagonist Recognition

  2008cited by this paper
• Sodium-coupled neurotransmitter transporters.

  2008cited by this paper
• Substrate binding and formation of an occluded state in the leucine transporter.

  2008cited by this paper
• Driving Forces for Ligand Migration in the Leucine Transporter

  2008cited by this paper
• Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter.

  2008cited by this paper
• The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site.

  2008influential reference
• A Competitive Inhibitor Traps LeuT in an Open-to-Out Conformation

  2008influential reference
• Symmetric Transporters for Asymmetric Transport

  2008cited by this paper
• Mechanism of chloride interaction with neurotransmitter:sodium symporters

  2007cited by this paper
• Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease.

  2007cited by this paper
• Identification of a chloride ion binding site in Na+/Cl−-dependent transporters

  2007cited by this paper
• Antidepressant binding site in a bacterial homologue of neurotransmitter transporters

  2007influential reference
• LeuT-Desipramine Structure Reveals How Antidepressants Block Neurotransmitter Reuptake

  2007cited by this paper
• Tyr-95 and Ile-172 in Transmembrane Segments 1 and 3 of Human Serotonin Transporters Interact to Establish High Affinity Recognition of Antidepressants*

  2006cited by this paper
• Ligand-protein interaction in biomembrane carriers. The induced transition fit of transport catalysis.

  2005cited by this paper
• Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters

  2005cited by this paper
• High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions.

  2005cited by this paper
• Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysis.

  2003cited by this paper
• Plasma membrane monoamine transporters: structure, regulation and function

  2003cited by this paper
• Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor.

  2003cited by this paper
• Characterization of a Functional Bacterial Homologue of Sodium-dependent Neurotransmitter Transporters*

  2003cited by this paper
• The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP‐treated and levodopa‐primed common marmosets

  2002cited by this paper
• Mechanisms of Biogenic Amine Neurotransmitter Transporters

  2002cited by this paper
• Determination of Residues in the Norepinephrine Transporter That Are Critical for Tricyclic Antidepressant Affinity*

  2001cited by this paper
• Neurochemical neutralization of methamphetamine with high‐affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse

  2000cited by this paper
• Preferential Increases in Nucleus Accumbens Dopamine after Systemic Cocaine Administration Are Caused by Unique Characteristics of Dopamine Neurotransmission

  2000cited by this paper
• Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding

  1999cited by this paper
• Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.

  1999cited by this paper
• Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine.

  1998cited by this paper
• Pharmacological profile of antidepressants and related compounds at human monoamine transporters.

  1997cited by this paper
• Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.

  1996cited by this paper
• Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication.

  1995cited by this paper
• Development of antidepressant drugs. Fluoxetine (Prozac) and other selective serotonin uptake inhibitors.

  1995cited by this paper
• Development of Antidepressant Drugs

  1995cited by this paper
• A new pharmophoric model for 5-HT reuptake-inhibitors: differentiation of amphetamine analogues.

  1994cited by this paper
• Third‐generation antidepressants

  1993cited by this paper
• Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

  1987cited by this paper
• Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes.

  1985cited by this paper
• Nontricyclic antidepressant agents derived from cis- and trans-1-amino-4-aryltetralins.

  1984cited by this paper
• Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport.

  1979cited by this paper

• Insight into the Structure of the Neutral Amino Acid Transporter B0AT2 Enabled the Discovery of Tiagabine as an Inhibitor.

  2024cites this paper
• Allosteric modulation of serotonin and dopamine transporters: New insights from computations and experiments

  2024cites this paper
• (2-Cyclohexyl-1-methylpropyl) cyclohexane isolated from garlic extract exhibits antidepressant-like activity: extraction, docking, drug-like properties, molecular dynamics simulations and MM/GBSA studies

  2023influential citation
• Overview of the structure and function of the dopamine transporter and its protein interactions

  2023cites this paper
• Role of transmembrane helix 6 in substrate recognition of the amino acid transporter MhsT

  2020cites this paper
• Structure Modeling of the Norepinephrine Transporter

  2020cites this paper
• A non‐helical region in transmembrane helix 6 of hydrophobic amino acid transporter MhsT mediates substrate recognition

  2020cites this paper
• Identification of a New Allosteric Binding Site for Cocaine in Dopamine Transporter

  2020cites this paper
• Studies of structural determinants of substrate binding in the Creatine Transporter (CreaT, SLC6A8) using molecular models

  2020cites this paper
• Monoamine transporters: structure, intrinsic dynamics and allosteric regulation

  2019cites this paper
• Trimerization of dopamine transporter triggered by AIM-100 binding: Molecular mechanism and effect of mutations.

  2019cites this paper
• Tamoxifen Directly Interacts with the Dopamine Transporter

  2018cites this paper
• The LeuT-fold neurotransmitter:sodium symporter MhsT has two substrate sites

  2018cites this paper
• Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters.

  2018cites this paper
• Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases

  2017cites this paper
• Thyroid hormone transport across L-type amino acid transporters: What can molecular modelling tell us?

  2017cites this paper
• Atypical binding at dopamine and serotonin transporters contribute to the discriminative stimulus effects of mephedrone

  2017cites this paper
• Structure-function analysis of the dopamine transporter in the presence of synthetic cathinones and amphetamines

  2016cites this paper
• Modulation of Dopamine Transporter Function by Tamoxifen

  2016cites this paper
• Shared Molecular Mechanisms of Membrane Transporters.

  2016cites this paper
• DSP4, a Selective Neurotoxin for the Locus Coeruleus Noradrenergic System. A Review of Its Mode of Action

  2014cites this paper
• Understanding transporter specificity and the discrete appearance of channel-like gating domains in transporters

  2014cites this paper
• Dopamine transporter (DAT), nicotinic acetylcholine receptor (nAChR), and metabotropic glutamate receptor 2 (mGlu2) irreversible probes for identifying anti-psychostimulant therapeutics

  2014influential citation
• Dopamine transporter (DAT) and metabotropic glutamate receptor 5 (MGLU5) irreversible probes for identifying anti-psychostimulant therapeutics

  2014influential citation
• Characterizing the Structure, Function, and Evolution of Human Solute Carrier (SLC) Transporters Using Computational Approaches

  2014cites this paper
• Coupled global and local changes direct substrate translocation by neurotransmitter-sodium symporter ortholog LeuT.

  2013cites this paper
• Genetic, molecular, biochemical and biophysical approaches in studying structure – function relations in transmembrane purine transporters

  2013cites this paper
• Molecular insight into cell surface nutrient transporter quality control and downregulation in Saccharomyces cerevisiae

  2013cites this paper
• Molecular modeling and ligand docking for solute carrier (SLC) transporters.

  2013cites this paper
• SLC6 transporters: structure, function, regulation, disease association and therapeutics.

  2013cites this paper
• Visualizing Functional Motions of Membrane Transporters with Molecular Dynamics Simulations

  2013cites this paper
• Common folds and transport mechanisms of secondary active transporters.

  2013cites this paper
• The cost of living in the membrane: a case study of hydrophobic mismatch for the multi-segment protein LeuT.

  2013cites this paper
• Nonclassical Pharmacology of the Dopamine Transporter: Atypical Inhibitors, Allosteric Modulators, and Partial Substrates

  2013cites this paper
• Novel C-1 Substituted Cocaine Analogs Unlike Cocaine or Benztropine

  2012cites this paper
• Inhibitory Action of Antidepressants on Mouse Betaine/GABA Transporter (BGT1) Heterologously Expressed in Cell Cultures

  2012cites this paper
• It takes two to transport, or is it one?

  2012cites this paper
• High Selectivity of the γ-Aminobutyric Acid Transporter 2 (GAT-2, SLC6A13) Revealed by Structure-based Approach*

  2012influential citation
• Identification of the Substrate Recognition and Transport Pathway in a Eukaryotic Member of the Nucleobase-Ascorbate Transporter (NAT) Family

  2012cites this paper
• Studies of the Biogenic Amine Transporters. 14. Identification of Low-Efficacy “Partial” Substrates for the Biogenic Amine Transporters

  2012influential citation
• Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET

  2011cites this paper
• Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters

  2011cites this paper
• Simple screening method for improving membrane protein thermostability.

  2011cites this paper